Clinical Trials in Pittsburgh

Showing 1281-1300 of 21,047 trials

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

NCT06729996

The purpose of this study is to evaluate efficacy of pioglitazone (PIO) versus empagliflozin (EMPA) to improve glycemic control in people with Chronic Pancreatitis (CP) or Recurrent Acute Pancreatitis (RAP) associated with Diabetes Mellitus (DM). To evaluate mixed meal response in PIO versus EMPA group to better understand physiology of both therapies in CP-DM.

Pancreatitis, ChronicPancreatitis, AcuteDiabetes Mellitus

Mayo Clinic40 participantsStarted May 2025

Rochester, Minnesota, United States • Pittsburgh, Pennsylvania, United States

RECRUITINGPhase 256 miles

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

NCT02932150

The goals of this clinical study are to compare the effectiveness, safety and tolerability of study drug, tenofovir alafenamide (TAF), versus placebo in teens and children with CHB and to learn more about the dosing levels in children.

Chronic Hepatitis B

Gilead Sciences150 participantsStarted Nov 2016

Los Angeles, California, United States • San Diego, California, United States • San Francisco, California, United States +59 more locations

Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus

Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chronic Hepatitis B Virus Infection

Find Trials by Condition in Pittsburgh

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Combination Short-Acting BroNchodilator and Inhaled Corticosteroid Rescue Therapy on Health Outcomes in Routine Care

Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials

A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis

A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease

Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

Real World Evidence Study in Subjects With Wilson's Disease

Single Agent Pembrolizumab in Subjects With Advanced Adrenocortical Carcinoma

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

EVR and EPO for Liver Transplant Tolerance

RemI for Post-Bariatric Surgery Weight Regain

Osimertinib, Surgery, and Radiation Therapy in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer With EGFR Mutations, NORTHSTAR Study

Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia

Implementing Depression and Adherence Treatment

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome